Viratek Inc.: The Costa Mesa drug discovery...

Viratek Inc.: The Costa Mesa drug discovery and development company lost $1.8 million, or 10 cents a share, for the second quarter. That compared to a loss of $1.1 million, or 7 cents a share, for the comparable 1993 period. Revenue was $758,000, 40% higher than the $540,000 recorded for the same period a year earlier. For the first half, the company reported a loss of $1.3 million, or 7 cents a share, compared to a loss of $822,000, or 5 cents a share, for the same period a year earlier. Six-month revenue was upto $3.6 million from $2 million.